Clinical trials: Dermatitis Hand

Chronic Hand Eczema

Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema

• Completed
• Age: 18 years and older
• Phase 1/2
• Results posted

This study will assess the safety and efficacy of ARQ-252 cream in subjects with chronic hand eczema

Trial name

NCT04378569

Testing

ARQ-252 cream 0.3%, ARQ-252 cream 0.1%, ARQ-252 Vehicle Cream

Where

37 sites in United States, Australia and 1 more

Volunteers

230 people

Sponsor

Arcutis Biotherapeutics, Inc.